World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
26998
World Ranking
11001
National Ranking
5660

Overview

Harland N. Sather is affiliated with the University of Southern California in the United States. The academic profile available for this researcher shows a career grounded primarily in this institution.

While specific details about publications, research topics, and coauthors are not outlined in the available data, their contributions are situated within the broader scope of their primary affiliation, suggesting involvement in the academic community at USC.

The absence of listed recent papers, frequent coauthors, publication venues, or book publications indicates that further information might be necessary to fully map the extent of this scientist's research output and collaborations.

There are no awards recorded for Harland N. Sather in the provided data, nor is there detailed evidence regarding fields or subfields of study and main topics, which limits the profiling to focusing primarily on institutional association.

Harland N. Sather is noted as living, therefore their work and academic contributions may continue to develop. The objective presentation of this profile reflects the currently available public scholarly record without extrapolating beyond the data provided.

Best Publications

  • Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

    Robert C. Seeger;Garrett M. Brodeur;Harland Sather;Andree Dalton

  • Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

    M Smith;D Arthur;B Camitta;A J Carroll

  • Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

    Kirk R. Schultz;W. Paul Bowman;Alexander Aledo;William B. Slayton

  • Second neoplasms after acute lymphoblastic leukemia in childhood.

    Neglia Jp;Meadows At;Robison Ll;Kim Th

  • A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a children's Cancer Group Study

    Vassilios I. Avramis;Susan Sencer;Antonia P. Periclou;Harland Sather

  • Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

    Kirk R. Schultz;D. Jeanette Pullen;Harland N. Sather;Jonathan J. Shuster

  • Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.

    James B. Nachman;Harland N. Sather;Martha G. Sensel;Michael E. Trigg

  • Osteonecrosis as a Complication of Treating Acute Lymphoblastic Leukemia in Children: A Report From the Children’s Cancer Group

    Leonard A. Mattano;Harland N. Sather;Michael E. Trigg;James B. Nachman

  • Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.

    Bruce C. Bostrom;Martha R. Sensel;Harland N. Sather;Paul S. Gaynon

  • Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

    Nita L. Seibel;Peter G. Steinherz;Harland N. Sather;James B. Nachman

  • Long Term Results of the Children’s Cancer Group Studies for Childhood Acute Lymphoblastic Leukemia 1983–2002: a Children’s Oncology Group Report

    Paul S. Gaynon;Paul S. Gaynon;Anne L. Angiolillo;William L. Carroll;James B. Nachman

  • Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

    Joanne M. Hilden;Patricia A. Dinndorf;Sharon O. Meerbaum;Harland Sather

  • Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia

    James B. Nachman;Nyla A. Heerema;Harland Sather;Bruce Camitta

  • Racial and ethnic differences in survival of children with acute lymphoblastic leukemia

    Smita Bhatia;Harland N. Sather;Nyla A. Heerema;Michael E. Trigg

  • Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.

    Eduard H Panosyan;Nita L Seibel;Sagrario Martin-Aragon;Paul S Gaynon

  • Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.

    CH Pui;JM Chessells;B Camitta;A Baruchel

  • Early Response to Therapy and Outcome in Childhood Acute Lymphoblastic Leukemia A Review

    Paul S. Gaynon;Anish A. Desai;Bruce C. Bostrom;Raymond J. Hutchinson

  • Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in Neuroblastoma

    T J Moss;C P Reynolds;H N Sather;S G Romansky

  • Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group.

    Leslie L. Robison;Mark E. Nesbit;Harland N. Sather;Carolyn Level

  • Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia: A report from Childrens Cancer Study Group

    Leslie L. Robison;Harland N. Sather;Peter F. Coccia;Mark E. Nesbit

Frequent Co-Authors

Paul S. Gaynon
Paul S. Gaynon University of Southern California
Nyla A. Heerema
Nyla A. Heerema The Ohio State University
Fatih M. Uckun
Fatih M. Uckun University of Southern California
Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Meenakshi Devidas
Meenakshi Devidas St. Jude Children's Research Hospital
Mark E. Nesbit
Mark E. Nesbit University of Minnesota
Beverly J. Lange
Beverly J. Lange Children's Hospital of Philadelphia
William L. Carroll
William L. Carroll New York University
Diane C. Arthur
Diane C. Arthur National Institutes of Health
Leslie L. Robison
Leslie L. Robison St. Jude Children's Research Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative routes in healthcare education can open up new opportunities for those interested in medical careers in the USA. Many students seek degree options that offer greater flexibility, faster completion times, and fewer in-person requirements.

For registered nurses, rn to bsn no clinical hours programs provide a convenient way to advance qualifications online without needing to complete additional on-site clinical work. If you're looking to advance further, shortest dnp programs online offer rigorous training at a quicker pace, helping professionals earn their Doctor of Nursing Practice degree efficiently.

Some nursing professionals may prioritize minimal clinical requirements. Options like a dnp program without clinical hours can streamline the process and reduce the logistical challenges of traditional graduate education. Meanwhile, those starting their journey in healthcare may consider an accelerated lpn pathway, which compresses essential coursework and hands-on training for faster workforce entry.

Each of these diverse online options can help students achieve their educational and career goals—all with greater adaptability and speed.

Best Scientists Citing Harland N. Sather

Trending Scientists